Skip to main content
Premium Trial:

Request an Annual Quote

Genetron Health: Yun-Fu Hu

Chinese precision oncology company Genetron Holdings (Genetron Health) has appointed Yun-Fu Hu as chief medical officer. A former deputy director with the US Food and Drug Administration, Hu will be tasked to guide the company in its in vitro diagnostic device registration and regulatory affairs as well as its biopharma services business. At the FDA Hu led a team in premarket reviews and post-market compliance of IVD products and laboratory-developed tests for genetic testing, molecular cancer diagnostics, companion diagnostics, radiodosimetry, digital pathology, and artificial intelligence devices. Prior to joining FDA, Hu had more than 10 years of product development experience in the diagnostic and pharmaceutical industries.

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.